Correlations between APOBEC expression and immune cell markers across 22 cancer types. Correlations between APOBEC expression and immune cell markers across.

Slides:



Advertisements
Similar presentations
The expression and signaling of FGFR3 in WM cells.
Advertisements

A B C Supplementary figure S7
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Correlation coefficient
Figure 2 The association between CD8+ T‑cell density of the tumour
PD-1 and LAG-3 expression in MSI and MSS colorectal cancer specimens.
TIE2hi/VEGFAhi TEMs are present in the TMEM
IHC staining of FFPE esophageal tissues in tissue microarrays (×20).
Identification of a MEK2 mutation in a melanoma sample resistant to dabrafenib/trametinib. Identification of a MEK2 mutation in a melanoma sample resistant.
Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
H31m1-PDL1 cells form progressively growing tumors in WT mice.
Alterations related to androgen signaling.
Robustness of TRU, Proximal-proliferative (PP), and Proximal-inflammatory (PI) classification. Robustness of TRU, Proximal-proliferative (PP), and Proximal-inflammatory.
Quantification of MHC-I, β2m, and T-cell subsets.
LATS2-associated gene expression pattern is down-regulated specifically in lumB breast tumors. LATS2-associated gene expression pattern is down-regulated.
Drug sensitivity predictions from CCLE data.
Derivation of ImSig. Derivation of ImSig. A, An example of a correlation network generated from a tissue data set where nodes represent unique genes and.
Mice immunized twice with RRBC showed superior protection to tumor challenge with αGal-positive MC38 colon carcinoma cells compared with mock-immunized.
Specificity of HOM-MEL-40/SSX2 p stimulated CD8+ T-cells.
Geographic colocalization of PD-L1+ tumor cells with infiltrating immune cells in MCC. The predominant pattern of tumor cell PD-L1 expression is at the.
Expression profile of RSPO1 and 2 in gastric cancer.
PD-L1 expression correlates with T-cell markers and an IFN response signature in human melanomas. PD-L1 expression correlates with T-cell markers and an.
Landscape of the TME in gastric cancer and characteristics of TME subtypes. Landscape of the TME in gastric cancer and characteristics of TME subtypes.
Protein expression profile in a dasatinib-resistant cell line.
Colony-forming capacity of CD34+ cells with and without CLL-1 expression. Colony-forming capacity of CD34+ cells with and without CLL-1 expression. CD34+
Immune signatures of patients with short-, medium-, and long-term survival. Immune signatures of patients with short-, medium-, and long-term survival.
CLL-1 expression in patients with AML and normal donors.
Ki-67 expression is determined by the cell-cycle stage.
Greater induction of apoptosis following EGFR TKI treatment correlates with higher basal BIM expression across a panel of EGFR-mutant lung cancers. Greater.
Relationship between the expression of immune-related genes and burdens of somatic mutation. Relationship between the expression of immune-related genes.
Specific up-regulation and down-regulation of immunomodulatory genes in human breast and colorectal cancers. Specific up-regulation and down-regulation.
A, unsupervised clustering of all BRCA1 (red), BRCA2 (blue), and sporadic (green) breast tumors of our collection using the regions reported as discriminative.
A, Proportion of variants detected in the MMR genes.
Differential methylation at 12 selected HPV16 CpGs in cervical cells from premalignant lesions with biopsy-confirmed diagnoses from our original study.
Transcripts enriched and depleted in NB TICs compared with SKPs and other tumor tissues. Transcripts enriched and depleted in NB TICs compared with SKPs.
PAP- and PA2024-specific CTLs at week 0 (prior to sipuleucel-T infusion) and at weeks 6 and 26 post–sipuleucel-T treatment. PAP- and PA2024-specific CTLs.
Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.
Ki-67 expression in M31- and H3-treated tumors (A) and respective Ki-67 labeling indices in the two groups of tumors (B). Ki-67 expression in M31- and.
Gene expression levels of ESR1 (A), ERBB2 (B), MiK67(C), and PCNA (D) in pre- and postneoadjuvant chemotherapy samples (n = 21). Gene expression levels.
Bortezomib induces an NRF2 signature and NRF2 protein in tumor cells from leukemic MCL. Gene sets regulated by bortezomib (Supplementary Tables S3 and.
NKT cell recognition of CD1d1 molecules is inhibited by treatment with ascites. NKT cell recognition of CD1d1 molecules is inhibited by treatment with.
PD-L1 is expressed in breast cancer.
Distribution of FGFR aberrancies in urothelial cancers.
Correlations of the breast cancer hypoxia metagene with Ki67 and the proliferation metagene. Correlations of the breast cancer hypoxia metagene with Ki67.
Kaplan–Meier curves for RFS and OS by various marker groups.
Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8 and Stat3+/+:HPV8 mice. Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8.
Expression of HO-1 by the FAP+/F4/80+ tumoral macrophages.
Change in FES uptake in the tumor during fulvestrant treatment.
CD24 expression. CD24 expression. A, By global gene expression, CD24 is found to be highly upregulated in SEF (80×) and in LGFMS (37×) as compared with.
ROC analysis of MIC-1 and CA19-9.
Global mutational landscape of the 170 lung adenocarcinoma patients (discovery cohort). Global mutational landscape of the 170 lung adenocarcinoma patients.
Molecular definitions of lung adenocarcinoma subtypes.
Combination of R848 and anti-CD200R affects activation of tumor-infiltrating myeloid cells. Combination of R848 and anti-CD200R affects activation of tumor-infiltrating.
Effect of MZ treatment on lung colony formation in an experimental metastasis. Effect of MZ treatment on lung colony formation in an experimental metastasis.
Ibrutinib decreases ofatumumab-mediated complement-dependent cytotoxicity. Ibrutinib decreases ofatumumab-mediated complement-dependent cytotoxicity. A,
Transfection efficiency and PicoGreen cell survival assays.
Immune profiling of patient-derived organotypic tumor spheroids.
MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.
Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.
A, heatmap of copy number alterations determined by array CGH for a panel of 79 frozen NSCLC samples. A, heatmap of copy number alterations determined.
Venn diagram showing the overlap of PD-L1 overexpression, MSI-NGS–high, and TML-high in all gastrointestinal tumors, with all three markers tested (N =
Gene expression heatmap of non–T-cell-inflamed, intermediate, and T-cell–inflamed testicular germ cell tumors from TCGA. Genes are on the row, and samples.
PTEN genotype frequently dictates PTEN expression status, but evidence of heterogeneous staining implies polyclonality within some ovarian tumors. PTEN.
Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.
Recruitment of CD8+, CD4+, and Foxp3+ cells into oral lesions in response to anti–PD-1 treatment. Recruitment of CD8+, CD4+, and Foxp3+ cells into oral.
Cell counts of immune infiltrate and expression of galectin-1 and galectin-3 in the short-, medium-, and long-term survival cohorts. Cell counts of immune.
Coincidence and prognostic significance of PD-1+ and CD103+ cells in HGSC. Serial sections from the 490-case TMA were stained with antibodies to CD103.
IHC staining of FFPE esophageal tissues in tissue microarrays (×20).
Correlation of TAN phenotypes and TIL effector function.
GSN and DNMT1 expression are inversely correlated in a pattern associated with patient survival. GSN and DNMT1 expression are inversely correlated in a.
Presentation transcript:

Correlations between APOBEC expression and immune cell markers across 22 cancer types. Correlations between APOBEC expression and immune cell markers across 22 cancer types. Heatmap of Spearman's correlation coefficients calculated from the comparison of the T-cell marker CD3D (A) or the B-cell marker CD20 (B) with the indicated APOBEC family member. Expression levels were determined using TCGA RNAseq data (see Supplementary Table S3 for the long form for each tumor abbreviation). Dark red squares indicate strong positive correlations, dark blue squares indicate strong negative correlations, and white squares indicate a lack of correlation. Brandon Leonard et al. Clin Cancer Res 2016;22:4746-4755 ©2016 by American Association for Cancer Research